SCHEMBL4154942

SCHEMBL4154942

[O]CCCNc1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHOC P08134 2/20 0.45
RHOA P61586 2/20 0.45
MAPT P10636 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CHRM1 P11229 1/20 0.42
HTR2A P28223 1/20 0.42
MCHR1 Q99705 1/20 0.42
GAA P10253 2/20 0.40
HDAC1 Q13547 1/20 0.39
FFAR1 O14842 1/20 0.39
PRSS1 P07477 2/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4155501 0.86 MEN1 (0.46) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL9639726 0.81 MAPT (0.55) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL908984 0.80 RHOC (0.46) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL4163405 0.80 ALDH1A1 (0.44) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL2091997 0.78 RHOC (0.45) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL7793228 0.78 SMN1; SMN2 (0.56) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL909141 0.78 L3MBTL1 (0.47) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL11348193 0.78 STK17A (0.55) RHOCRHOAMAPTALDH1A1MEN1
SCHEMBL8871517 0.77 ALDH1A1 (0.73) MAPTALDH1A1MEN1KMT2AHDAC1
SCHEMBL7794052 0.77 ALDH1A1 (0.55) RHOCRHOAMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS LABORATORIOS SALVAT, S.A. (ES) 2009-04-02 US disclosed
US-7423172-B2 Tyrosine derivatives as PPAR-γ-modulators LABORATORIOS SALVAT, S.A. (ES) 2008-09-09 US disclosed
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators LABORATORIES SALVAT, S.A. (ES) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS PPARG, PPARD, TYRO3 RHOC 3490/4885RHOA 4360/4885MAPT 2739/4885
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators PPARG, PPARD, PPARA RHOC 3311/4885RHOA 4198/4885MAPT 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.